Risk Factors for Tardive Dyskinesia in Patients Taking Antipsychotics
The risk factors for tardive dyskinesia in patients taking antipsychotics include age, comorbid diagnoses, and high medication dosages.
The risk factors for tardive dyskinesia in patients taking antipsychotics include age, comorbid diagnoses, and high medication dosages.
Automated self-management with collaborative care from a nurse-physician team produced slightly greater improvements in pain and mood symptomsvs automated self-management alone.
Anticonvulsant mood stabilizers were not linked to a greater risk for placenta-mediated complications or preterm birth.
Youth who are readmitted for inpatient psychiatric care share such factors as foster care, comorbid conditions, and prior psychiatric hospitalizations.
Treatment with benzodiazepines for less than 3 months may not decrease the cognitive function of patients with major depressive disorder who are also prescribed antidepressants.
An increased risk for spontaneous abortion in early pregnancy was linked to incident exposure to short- and long-acting benzodiazepines.
The FDA has granted Fast Track status to the microbiota transfer therapy, Full-Spectrum Microbiota (FSM), for the treatment of children with autism spectrum disorder.
Ten of 18 reviewed treatment strategies linked to higher response versus sham therapy
Consistent with primary KINECT 3 study results, supplemental analyses indicate that participants treated with valbenazine had statistically significant improvements in tardive dyskinesia severity.
Anxiety, previous history of suicidal ideation and/or behavior, and race were associated with increased risk of adverse psychiatric events.